A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing.
Marta Díaz-NavarroRama HafianIrene ManzanoMaría J Pérez-GrandaEmilia CercenadoCristina PascualCarmen RodríguezPatricia MuñozMaría GuembePublished in: Infectious diseases and therapy (2022)
A dalbavancin lock solution can be frozen for up to 6 months with no negative effect on its bioactivity against enterococcal biofilms. However, when combined with heparin, its efficacy was reduced. Therefore, we recommend that if lock therapy with frozen dalbavancin is used in the management of enterococcal C-RBSI, heparin should be added simultaneously at the time of catheter lock.